Literature DB >> 24206074

Role of NMDA receptors in the trigeminal pathway, and the modulatory effect of magnesium in a model of rat temporomandibular joint arthritis.

André L C Cavalcante1, Rafaelly M P Siqueira, Joana C B Araujo, Delane V Gondim, Ronaldo A Ribeiro, Josiane S Quetz, Alexandre Havt, Aldo A M Lima, Mariana L Vale.   

Abstract

Temporomandibular joint (TMJ) arthritis is a common cause of orofacial pain. In the present study, the modulatory effects of N-methyl-d-aspartate receptors (NMDA-Rs) and magnesium were investigated in TMJ arthritis hypernociception. Male Wistar rats received an intra-articular injection of carrageenan (Cg) in the TMJ, and mechanical hypernociception was measured. The NMDA-R antagonist, MK-801, and magnesium chloride (MgCl₂ ) were administered before arthritis induction. Magnesium deficiency was promoted by feeding rats a synthetic magnesium-free diet for 9 d before injection of Cg. The Cg induced mechanical hypernociception that lasted for 120 h. MK-801 inhibited this hypernociceptive state. MgCl₂ pretreatment prevented Cg-induced hypernociception and altered the nociceptive threshold in the absence of Cg. Magnesium deficiency increased hypernociception and induced spontaneous hypernociceptive behavior. TMJ arthritis increased the expression of mRNA for all NMDA-R subunits and immunostaining of phosphorylated NR1 (phospho-NR1). MgCl₂ inhibited expression of NR2B mRNA and phospho-NR1 immunostaining and increased expression of NR3 mRNA. Magnesium deficiency increased expression of both NR1 and NR3 mRNAs and phospho-NR1 immunostaining in the trigeminal subnucleus caudalis. We found that magnesium modulates nociceptive behavior and induces NMDA-R subunit rearrangement in the subnucleus caudalis. The present results may lead to a better understanding of central processing in the nociceptive trigeminal pathway and the development of new approaches to treat orofacial pain with a TMJ origin.
© 2013 Eur J Oral Sci.

Entities:  

Keywords:  N-methyl-d-aspartate receptor (NMDA-R); NR3; magnesium; orofacial pain; temporomandibular joint

Mesh:

Substances:

Year:  2013        PMID: 24206074     DOI: 10.1111/eos.12093

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  6 in total

1.  Occlusal Disharmony-A Potential Factor Promoting Depression in a Rat Model.

Authors:  Sihui Zhang; Ling Wu; Mi Zhang; Kaixun He; Xudong Wang; Yuxuan Lin; Shuxian Li; Jiang Chen
Journal:  Brain Sci       Date:  2022-06-07

2.  The synergistic effect of treatment with triptolide and MK-801 in the rat neuropathic pain model.

Authors:  Jian Wang; Yu Qiao; Ri-Sheng Yang; Chun-Kui Zhang; Huang-Hui Wu; Jia-Ji Lin; Ting Zhang; Tao Chen; Yun-Qing Li; Yu-Lin Dong; Jin-Lian Li
Journal:  Mol Pain       Date:  2017-11-22       Impact factor: 3.395

3.  Effects of magnesium with or without boron on headshaking behavior in horses with trigeminal-mediated headshaking.

Authors:  Shara A Sheldon; Monica Aleman; Lais R R Costa; Kalie Weich; Quinn Howey; John E Madigan
Journal:  J Vet Intern Med       Date:  2019-04-16       Impact factor: 3.333

Review 4.  Role of N-Methyl-D-Aspartate Receptor NR2B Subunit in Inflammatory Arthritis-Induced Chronic Pain and Peripheral Sensitized Neuropathic Pain: A Systematic Review.

Authors:  Yu Meng; Hai Li Shen
Journal:  J Pain Res       Date:  2022-07-18       Impact factor: 2.832

Review 5.  NMDARs mediate peripheral and central sensitization contributing to chronic orofacial pain.

Authors:  Ya-Jing Liu; Yue-Ling Li; Zhong-Han Fang; Hong-Lin Liao; Yan-Yan Zhang; Jiu Lin; Fei Liu; Jie-Fei Shen
Journal:  Front Cell Neurosci       Date:  2022-09-27       Impact factor: 6.147

6.  Tyrosine Kinase Inhibitors Reduce NMDA NR1 Subunit Expression, Nuclear Translocation, and Behavioral Pain Measures in Experimental Arthritis.

Authors:  Karin N Westlund; Ying Lu; Liping Zhang; Todd C Pappas; Wen-Ru Zhang; Giulio Taglialatela; Sabrina L McIlwrath; Terry A McNearney
Journal:  Front Physiol       Date:  2020-05-27       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.